Association between the Growth Hormone Receptor Exon 3 Polymorphism and Metabolic Factors in Korean Patients with Acromegaly

Association between the Growth Hormone Receptor Exon 3 Polymorphism and Metabolic Factors in Korean Patients with Acromegaly

BackgroundThis study investigated the association between the frequency of growth hormone receptor (GHR) exon 3 polymorphism (exon 3 deletion; d3-GHR) and metabolic factors in patients with acromegaly in Korea.MethodsDNA was extracted from the peripheral blood of 30 unrelated patients with acromegal...

Full description

Bibliographic Details
Main Authors:	Hye Yoon Park, In Ryang Hwang, Jung Bum Seo, Su Won Kim, Hyun Ae Seo, In Kyu Lee, Jung Guk Kim
Format:	Article
Language:	English
Published:	Korean Endocrine Society 2015-09-01
Series:	Endocrinology and Metabolism
Subjects:	Growth hormone receptor exon 3 deletion Polymorphism Acromegaly Body mass index Fasting plasma glucose
Online Access:	http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-30-312.pdf

Similar Items

Using Growth Hormone Levels to Detect Macroadenoma in Patients with Acromegaly
by: Ji Young Park, et al.
Published: (2014-12-01)

Early postoperative measurement of growth hormone level for prognosis of surgical outcomes in acromegaly
by: A. I. Tsiberkin, et al.
Published: (2020-11-01)

The Exon 3-Deleted Growth Hormone Receptor (d3GHR) Polymorphism—A Favorable Backdoor Mechanism for the GHR Function
by: Ghadeer Falah, et al.
Published: (2023-09-01)

Characteristics of Acromegaly in Korea with a Literature Review
by: Jae Won Hong, et al.
Published: (2013-09-01)

Secondary erythrocytosis in patient with acromegaly
Published: (2011-12-01)

Oral disorders related to acromegaly
by: Akram Belmehdi, et al.
Published: (2019-10-01)

Cutis verticis gyrata: a cutaneous finding in acromegaly
by: Giullia Menuci Chianca Landenberger, et al.
Published: (2022-06-01)

The Biochemical Diagnosis of Acromegaly
by: Amit Akirov, et al.
Published: (2021-03-01)

Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly
by: Tyler Cardinal, et al.
Published: (2021-11-01)

Serum Phosphorus and Calcium as Biomarkers of Disease Status in Acromegaly
by: Nadia Sawicka-Gutaj, et al.
Published: (2023-12-01)

Acromegaly presenting as obstructive sleep apnea syndrome
by: Deepthi Laldayal, et al.
Published: (2017-01-01)

Approach of Acromegaly during Pregnancy
by: Alexandru Dan Popescu, et al.
Published: (2022-11-01)

Risk factors for glucose intolerance in active acromegaly
by: Kreze A., et al.
Published: (2001-01-01)

Multiomics Approach to Acromegaly: Unveiling Translational Insights for Precision Medicine
by: Kyungwon Kim, et al.
Published: (2023-10-01)

Pegvisomant and current approaches to the medical treatment of acromegaly (literature review and case report)
by: Larisa K. Dzeranova, et al.
Published: (2019-12-01)

Novel Exon-Skipping Therapeutic Approach for the DMD Gene Based on Asymptomatic Deletions of Exon 49
by: Mario Abaji, et al.
Published: (2022-07-01)

Quality of Life in Acromegaly Disease Among Iranian Population:One Longitudinal Before-After Study
by: Arezoo Chouhdari, et al.
Published: (2023-06-01)

An Overview of the Musculoskeletal Comorbidity of Acromegaly: A Case with Non-traumatic Spontaneous Rectus Femoris Rupture
by: Nurdan Yılmaz, et al.
Published: (2021-04-01)

Hand measurements in the follow-up of acromegaly
by: F Tarhan, et al.
Published: (2013-09-01)

Investigating the Implications of CFTR Exon Skipping Using a Cftr Exon 9 Deleted Mouse Model
by: Kelly M. Martinovich, et al.
Published: (2022-03-01)

Hormonal regulation of menstrual function in patients of reproductive age with acromegaly
by: Svetlana Yu. Vorotnikova, et al.
Published: (2018-12-01)

Experience with pegvisomant treatment in acromegaly in a single Brazilian tertiary reference center: efficacy, safety and predictors of response
by: Leandro Kasuki, et al.
Published: (2016-10-01)

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
by: Sang Ouk Chin, et al.
Published: (2019-03-01)

The specifics of the course of pregnancy in women with acromegaly
by: S A Levakov, et al.
Published: (2016-08-01)

The acromegaly lipodystrophy
by: Pamela U. Freda
Published: (2022-09-01)

Acromegaly: a clinical perspective
by: Lima Lawrence, et al.
Published: (2020-08-01)

Brazilian multicenter study on pegvisomant treatment in acromegaly
by: Cesar L. Boguszewski, et al.

The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms
by: Taishu Wang, et al.
Published: (2018-07-01)

Diabetic retinopathy in acromegaly
by: Said Azzoug, et al.
Published: (2014-01-01)

Precision Therapy in Acromegaly Caused by Pituitary Tumors: How Close Is It to Reality?
by: Cheol Ryong Ku, et al.
Published: (2020-06-01)

Dual treatment of acromegaly and hormone-receptor-positive breast cancer with tamoxifen: a case report
by: Sasan Mirfakhraee, et al.
Published: (2021-04-01)

Acromegaly and hypertension
by: WANG Shu-chang, ZHU Hui-juan, PAN Hui
Published: (2021-09-01)

Disposition Index in Active Acromegaly
by: Dan Alexandru Niculescu, et al.
Published: (2019-09-01)

Multiple Myeloma in a Patient with Acromegaly
by: Yu Mi Kang, et al.
Published: (2015-03-01)

Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study
by: Christian Rosendal, et al.
Published: (2024-04-01)

Treatment update on acromegaly
by: Tatiana Hotimsky Millner, et al.
Published: (2004-12-01)

Editorial: Personalized management of acromegaly
by: Nicholas A. Tritos
Published: (2023-05-01)

Aneurysmal dilation of sinus of Valsalva in a patient with undiagnosed acromegaly
by: Hoda Gharoy, et al.
Published: (2023-12-01)

Cognitive Dysfunction, an Increasingly Valued Long-Term Impairment in Acromegaly
by: Juan Chen, et al.
Published: (2023-03-01)

A Zebrafish Acromegaly Model Elevates DNA Damage and Impairs DNA Repair Pathways
by: Abdalla Elbialy, et al.
Published: (2018-10-01)